VEUS is a fully automated diagnostic system for rapid detection of traumatic brain injury using blood-based biomarkers GFAP and UCH-L1. The platform employs magnetic particle immunoassay technology to deliver results within 15-50 minutes with high sensitivity and accuracy.
Manufactured by
South Korea
VEUS, the abbreviation of Versatile, Easy, and User-friendly System, is a diagnostic system: Versatile – almost all in vitro diagnostic items are applicable; Easy – the system entirely automated enabling easy testing with no pretreatment required; User-friendly – anybody can use the system easily. Furthermore, it delivers rapid and accurate results for efficient clinical decision-making.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
ABCDx
Spain · 3 relevant products
Rapid Technology LLC
Russia · 2 relevant products
Lansion Biotechnology Co., Ltd.
China · 1 relevant product
8 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 16 closest product alternatives
ABCDx · Spain
A point-of-care diagnostic solution powered by advanced blood-based biomarkers for brain injuries. LVOCheck is designed for the selection and triage of large vessel occlusion (LVO) stroke patients to identify those requiring rapid treatment. The platform utilizes proprietary Software as a Medical Device technology to differentiate between ischemic and haemorrhagic stroke and detect mild traumatic brain injury.
Rapid Technology LLC · Russia
Point-of-care diagnostic test for detecting ischemic stroke and traumatic brain injury based on biomarkers.
Lansion Biotechnology Co., Ltd. · China
In vitro diagnostic reagent for neurological injury assessment. Supports rapid detection of brain injury biomarkers.
13 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products